Chronic Hepatitis C
HEPATITIS C --- Navigation Topics
• Top New Articles on HCV
• All HCV Articles by Topic ( A to Z )
• HCV Basics
• HIV-HCV Coinfection
• FDA-approved Treatments for HCV
- Roferon A (interferon alfa-2a)
- Intron A (interferon alfa-2b)
- Infergen (consensus interferon)
- Pegasys (peginterferon alfa-2a)
- PegIntron (peginterferon alfa-2b)
- Copegus / Rebetol (ribavirin)
- Intron A + Rebetol
- Roferon A + Ribavirin
- Pegasys + Copegus
- PegIntron + Rebetol
• Treatment Guidelines for HCV
• Experimental Treatments for HCV
• Recent Research Conference Reports
• Tests for HCV
• Liver-related Complications
• Drug-related Adverse Events
• Doctor Is In 'Q and A' for HCV
• Library of CME Programs
• E-mail Update - Sign Up
• About Us - Contact Us
_______________
Liver Histology
Caffeine Linked to Reduced
Histological
Activity in People with Hepatitis C
11/17/06
Liver Histology
and Alanine Aminotransferase Levels in Children and Adults with Chronic Hepatitis C Infection
- 11/02/05
Effect of Significant
Histologic
Steatosis or Steatohepatitis on Response to Antiviral Therapy in Patients with Chronic Hepatitis C
- 6/29/05
Etanercept Treatment to Slow Fibrosis Progression Shows No
Histological
or Biochemical Improvement in Chronic HCV Genotype 1 Nonresponders to Peginterferon/Ribavirin
- 6/01/05
Association Between
Liver Histology
, Viral Kinetics and Outcome of Therapy with Peginterferon Alfa-2a (Pegasys) Combination Therapy with Ribavirin
- 4/22/05
Histologic
Benefit of Peginterferon Alfa-2a (Pegasys) Monotherapy in Chronic HCV Patients with Advanced Fibrosis or Cirrhosis
- 12/06/04
Confounding Finding of Lower Rates of Histologic Progression in HCV-HIV Coinfected Patients Versus HCV Mono-infected Inmates
- 06/04/04
Effect of Peginterferon Alfa-2a (Pegasys) on Liver Histology in Chronic Hepatitis C
- 02/27/04
Treatment with Pirfenidone for One Year Produces a Significant Reduction in Necroinflammation and Steatosis in Patients with Liver Cirrhosis
11/19/03
PEG-Intron Plus Ribavirin Improves Histology and Fibrosis in Nonresponders to Conventional Interferon and Ribavirin
11/07/03
Preemptive Therapy May Provide Important Histological Benefits in HCV Positive Liver Transplant Recipients
11/05/03
HIV AND AIDS
|
HEPATITIS B
|
HEPATITIS C
|
HIV / HBV CO-INFECTION
|
HIV / HCV CO-INFECTION
|
HEALTH AND TECHNOLOGY
|
TESTS
|
INTERNET CONFERENCE REPORTS
|
TELECONFERENCES
|
LINKS
|
ABOUT US
|
CONTACT US
